The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial
Clinical trial NCT03158935 · COMPLETED
Trial details
- NCT number
- NCT03158935
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-07
- Primary completion
- 2020-08-04
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.